LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, provided an update on its attendance at HLTH Europe 2026, a leading healthcare innovation conference. Management stated that the event allowed direct engagement with healthcare innovators, technology companies, providers, insurers, and digital health organizations from Europe, Latin America, and other international markets.
According to the company, HLTH Europe 2026 reinforced management’s belief that healthcare systems increasingly require integrated digital solutions to improve patient accessibility, care coordination, financial accessibility, and operational efficiency. Management observed growing interest in artificial intelligence applications, telehealth infrastructure, healthcare payments, insurance accessibility initiatives, and technology-enabled patient engagement solutions. The company noted that many themes discussed align closely with its ongoing efforts to develop an integrated healthcare ecosystem combining telehealth infrastructure, care coordination technologies, payment accessibility initiatives, insurance integration, pharmacy services, and AI-driven solutions.
The conference provided valuable opportunities to exchange ideas, evaluate emerging trends, and identify potential collaboration opportunities that may support LataMed AI's long-term platform strategy. Dr. Kevin Rodan Levy, CEO, stated: “HLTH Europe provided an outstanding opportunity to engage with healthcare and technology professionals from across Europe, Latin America, and other international markets. One of the most encouraging takeaways was the growing industry focus on integrated healthcare platforms that combine accessibility, coordination, financial solutions, and technology-enabled patient engagement. We believe these trends align closely with our broader healthcare ecosystem strategy and reinforce our long-term vision for LataMed AI.”
The company is reviewing follow-up opportunities from discussions held during the conference and intends to provide updates on material developments. Photographs and highlights are available through LataMed AI's official Instagram page. For additional information, visit https://latamed.ai or review SEC filings at www.sec.gov.
